Mohamed Shehata, MD, FESC, FSCAI

Lecturer and Consultant of Cardiology
Ain Shams University
Khalifa El-Maamoun St, Cairo
Cairo Governorate 11566, Egypt


Dr. Shehata was graduated from Ain Shams University medical school, Cairo, Egypt. He went through the academic cascade till being assigned as a Lecturer of Cardiology in the same institute. His duties included supervision of the Adult Cardiac Intervention Cath Lab & the Coronary Care Unit in Ain shams University hospital.

Research Interest

His research interests include: Adult coronary intervention, Patients management in coronary care unit, Acute cardiac care, Clinical cardiovascular pharmacology.

Scientific Activities

Professional Memberships & Fellowships

• Fellow of European Society of Cardiology (ESC)
• Fellow of The Society for Cardiovascular Angiography and Interventions (SCAI)
• Member of Acute Cardiac Care Association (ACCA)
• Member of European Association of Percutaneous Coronary Intervention (EAPCI)


International Publications:

1. Shehata M, Hamza M. Impact of High Loading Dose of Atorvastatin in Diabetic Patients with Renal Dysfunction Undergoing Elective Percutaneous Coronary Intervention: A Randomized Controlled Trial. Cardiovasc Ther. 2015. doi: 10.1111/1755-5922.12108
2. Shehata M. Value of Two-Dimensional Strain Imaging in Prediction of Myocardial Function Recovery after Percutaneous Revascularization of Infarct-Related Artery. Echocardiography. 2014. doi: 10.1111/echo.12704
3. Shehata M. Relation between ischemic threshold measured during dobutamine stress echocardiography and coronary angiographic features. Kardiol Pol. 2014. doi: 10.5603/KP.a2014.0111
4. Shehata M. Late re-assessment of myocardial viability after acute myocardial infarction: Is there still a chance? per title. Experimental & Clinical Cardiology. 2014; 20(1): 1062-1092.
5. Shehata M. Atropine first is safer than conventional atropine administration in older people undergoing dobutamine stress echocardiography. Ther Adv Cardiovasc Dis. 2014; 8(5): 176-184. doi: 10.1177/1753944714538112
6. Shehata M. Accelerated dobutamine stress testing: Feasibility and safety in patients with moderate aortic stenosis. The Egyptian Heart Journal. 2014. doi: 10.1016/j.ehj.2014.04.002
7. Shehata M. Impact of trimetazidine on incidence of myocardial injury and contrast-induced nephropathy in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention. Am J Cardiol. 2014; 114(3): 389-394. doi: 10.1016/j.amjcard.2014.04.052
8. Shehata M. Cardioprotective effects of oral nicorandil use in diabetic patients undergoing elective percutaneous coronary intervention. J Interv Cardiol. 2014; 27(5): 472-481. doi: 10.1111/joic.12142
9. Shehata M. Cardioprotective effects of intracoronary adenosine in diabetic patients undergoing elective percutaneous coronary intervention. Minerva Cardioangiol. 2014; 62(6): 461-471. doi: 10.1111/joic.12142
10. Shehata M. Angiographic and Clinical Impact of Successful Manual Thrombus Aspiration in Diabetic Patients Undergoing Primary PCI. Int J Vasc Med. 2014; 2014: 263926. doi: 10.1155/2014/263926
11. Shehata M. Cardioprotective Effects of Oral Trimetazidine in Diabetic Patients With Anterior Wall Myocardial Infarction Treated With Thrombolysis. Cardiology Research. 2014; 5(2): 58-67. doi: 10.14740/cr330w
12. Shehata M, AbdElhalim B, Hanna H, Nabih M. Postoperative Tachyarrhythmias: On-Pump versus Off-Pump Coronary Artery Bypass Grafting. ISRN Vascular Medicine. 2014. doi: 10.1155/2014/659706
13. Shehata M. Nicorandil: what is beyond the anti-anginal action?. Heart Res Open J. 2015; 2(4): e6-e8. doi: 10.17140/HROJ-2-e003